Cargando…

Immune cell profiling and antibody responses in patients with COVID-19

BACKGROUND: Although there are a growing number of studies on evaluating lymphocyte subset counts as prognostic factors for COVID-19 disease severity, the lymphocyte subsets’ analyses of both IgM and IgG responders and non-responders during the periods after onset of symptoms, have not been conducte...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaei, Mitra, Mahmoudi, Shima, Mortaz, Esmaeil, Marjani, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256640/
https://www.ncbi.nlm.nih.gov/pubmed/34225645
http://dx.doi.org/10.1186/s12879-021-06278-2
_version_ 1783718138207010816
author Rezaei, Mitra
Mahmoudi, Shima
Mortaz, Esmaeil
Marjani, Majid
author_facet Rezaei, Mitra
Mahmoudi, Shima
Mortaz, Esmaeil
Marjani, Majid
author_sort Rezaei, Mitra
collection PubMed
description BACKGROUND: Although there are a growing number of studies on evaluating lymphocyte subset counts as prognostic factors for COVID-19 disease severity, the lymphocyte subsets’ analyses of both IgM and IgG responders and non-responders during the periods after onset of symptoms, have not been conducted yet. So, this study aimed to evaluate immune cell profiling of COVID-19 patients with and without antibody responses. METHODS: In this cross-sectional study, the levels of peripheral lymphocyte subsets were measured using flow cytometry in 53 patients with positive SARS-CoV-2 RT-PCR, for whom antibody testing of COVID-19 was performed. RESULTS: The white blood cell, neutrophil, and lymphocyte counts consistently decreased in the IgM and IgG non-responder group, while the differences in the median value between the two study groups were found to be statistically significant only in terms of neutrophil counts (P = 0.024 for IgM response and p-value = 0.046 for IgG response, respectively). Moreover, the level of neutrophil-to-lymphocyte ratio was observed to be significantly lower in the IgM or IgG non-responder group compared to the IgM or IgG responder group (3.6 ± 3.1 vs. 6.3 ± 4.2; p-value = 0.021). The patients with IgM antibody response had a significantly lower CD20(+) lymphocytes (11% versus 15% in the groups without IgM antibody response, p-value = 0.031), The percentages of NK cells and CD4(+) T cells significantly increased in the patients with IgG antibody response compared to those without IgG antibody response (13% versus 10%, p-value = 0.028, and 41.5% versus 34%; p-value = 0.03, respectively). Moreover, the patients who produced IgM or IgG antibody had significantly higher percentages of total T lymphocytes (64% versus 54%; p-value = 0.017), CD4(+) T cells (41% versus 34%; p-value = 0.038), and NK cells (13% versus 9%, p-value = 0.023) compared to the group with no serological response. No significant difference was observed in the percentage of other lymphocyte subsets, including CD8(+) T cells, T(reg) cells, and CD19(+) B cells. CONCLUSION: Our results suggest that the total T cells, CD4(+) T cells, and NK cells percentages are linked to serological response. Moreover, our findings suggested that neutrophil absolute counts and neutrophil-to-lymphocyte ratio may be valuable predictors of IgM or IgG antibody response. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06278-2.
format Online
Article
Text
id pubmed-8256640
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82566402021-07-06 Immune cell profiling and antibody responses in patients with COVID-19 Rezaei, Mitra Mahmoudi, Shima Mortaz, Esmaeil Marjani, Majid BMC Infect Dis Research Article BACKGROUND: Although there are a growing number of studies on evaluating lymphocyte subset counts as prognostic factors for COVID-19 disease severity, the lymphocyte subsets’ analyses of both IgM and IgG responders and non-responders during the periods after onset of symptoms, have not been conducted yet. So, this study aimed to evaluate immune cell profiling of COVID-19 patients with and without antibody responses. METHODS: In this cross-sectional study, the levels of peripheral lymphocyte subsets were measured using flow cytometry in 53 patients with positive SARS-CoV-2 RT-PCR, for whom antibody testing of COVID-19 was performed. RESULTS: The white blood cell, neutrophil, and lymphocyte counts consistently decreased in the IgM and IgG non-responder group, while the differences in the median value between the two study groups were found to be statistically significant only in terms of neutrophil counts (P = 0.024 for IgM response and p-value = 0.046 for IgG response, respectively). Moreover, the level of neutrophil-to-lymphocyte ratio was observed to be significantly lower in the IgM or IgG non-responder group compared to the IgM or IgG responder group (3.6 ± 3.1 vs. 6.3 ± 4.2; p-value = 0.021). The patients with IgM antibody response had a significantly lower CD20(+) lymphocytes (11% versus 15% in the groups without IgM antibody response, p-value = 0.031), The percentages of NK cells and CD4(+) T cells significantly increased in the patients with IgG antibody response compared to those without IgG antibody response (13% versus 10%, p-value = 0.028, and 41.5% versus 34%; p-value = 0.03, respectively). Moreover, the patients who produced IgM or IgG antibody had significantly higher percentages of total T lymphocytes (64% versus 54%; p-value = 0.017), CD4(+) T cells (41% versus 34%; p-value = 0.038), and NK cells (13% versus 9%, p-value = 0.023) compared to the group with no serological response. No significant difference was observed in the percentage of other lymphocyte subsets, including CD8(+) T cells, T(reg) cells, and CD19(+) B cells. CONCLUSION: Our results suggest that the total T cells, CD4(+) T cells, and NK cells percentages are linked to serological response. Moreover, our findings suggested that neutrophil absolute counts and neutrophil-to-lymphocyte ratio may be valuable predictors of IgM or IgG antibody response. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06278-2. BioMed Central 2021-07-05 /pmc/articles/PMC8256640/ /pubmed/34225645 http://dx.doi.org/10.1186/s12879-021-06278-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Rezaei, Mitra
Mahmoudi, Shima
Mortaz, Esmaeil
Marjani, Majid
Immune cell profiling and antibody responses in patients with COVID-19
title Immune cell profiling and antibody responses in patients with COVID-19
title_full Immune cell profiling and antibody responses in patients with COVID-19
title_fullStr Immune cell profiling and antibody responses in patients with COVID-19
title_full_unstemmed Immune cell profiling and antibody responses in patients with COVID-19
title_short Immune cell profiling and antibody responses in patients with COVID-19
title_sort immune cell profiling and antibody responses in patients with covid-19
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256640/
https://www.ncbi.nlm.nih.gov/pubmed/34225645
http://dx.doi.org/10.1186/s12879-021-06278-2
work_keys_str_mv AT rezaeimitra immunecellprofilingandantibodyresponsesinpatientswithcovid19
AT mahmoudishima immunecellprofilingandantibodyresponsesinpatientswithcovid19
AT mortazesmaeil immunecellprofilingandantibodyresponsesinpatientswithcovid19
AT marjanimajid immunecellprofilingandantibodyresponsesinpatientswithcovid19